Table 3 Sexual health variables stratified by being in the concordant (both perceived and clinically assessed low risk of HIV) or discordant group (perceived low risk of HIV and clinically assessed high risk of HIV).

HIRI-MSM score, median (Q1-Q3)

6 (3–8)

18 (15–21)

z = -15.023 (p < 0.001)

Number sexual partners, median (Q1-Q3)

2 (1–3)

3 (1–5)

z = -4.752 (p < 0.001)

Number sexual partners HIV(+), median (Q1-Q3)

0 (0–0)

0 (0–1)

z = -4.297 (p < 0.001)

Syphilis diagnosis

n

%

n

%

Ever

15

12%

26

26%

Chi2 = 6.365, Cramer’s V = 0.164, (p = 0.012)

In the past year

4

3%

7

7%

Chi2 = 1.609, Cramer’s V = 0.083, (p = 0.205)

Chlamydia diagnosis

Ever

32

23%

47

41%

Chi2 = 8.832, Cramer’s V = 0.187, (p = 0.003)

In the past year

13

10%

17

16%

Chi2 = 1.991, Cramer’s V = 0.090, (p = 0.158)

Rectal, ever†

3

9%

14

38%

Chi2 = 8.541, Cramer’s V = 0.344, (p = 0.003)

Gonorrhea diagnosis

Ever

37

27%

54

44%

Chi2 = 8.906, Cramer’s V = 0.185, (p = 0.003)

In the past year

13

10%

21

19%

Chi2 = 4.455, Cramer’s V = 0.133, 

(p = 0.035)

Rectal, ever†

5

14%

22

48%

Chi2 = 10.062, Cramer’s V = 0.353, (p = 0.002)

Use of PEP at least twice

5

3%

9

6%

Chi2 = 1.896, Cramer’s V = 0.078,

(p = 0.169)

Methamphetamines use, past 6 months

1

1%

13

9%

Chi2 = 12.846, Cramer’s V = 0.202 (p < 0.001)

Poppers use, past 6 months

29

17%

50

34%

Chi2 = 12.438, Cramer’s V = 0.199 (p < 0.001)

Frequency of HIV testing

Once every 3 months or more often

25

16%

17

12%

Chi2 = 2.410, Cramer’s V = 0.089 (p = 0.300)

Once every 6 months or one year

97

60%

99

69%

Once every 2 years or less often

39

24%

28

19%